Amsterdam Public Health
-
Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML
Tettero, J. M., Buisman, Y., Ngai, L. L., Bachas, C., Gjertsen, B. T., Kelder, A., van de Loosdrecht, A. A., Manz, M. G., Pabst, T., Scholten, W., Ossenkoppele, G. J., Cloos, J. & de Leeuw, D. C., 21 Dec 2023, In: HemaSphere. 7, 12, p. E981Research output: Contribution to journal › Article › Academic › peer-review
-
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry
Tettero, J. M., Dakappagari, N., Heidinga, M. E., Oussoren-Brockhoff, Y., Hanekamp, D., Pahuja, A., Burns, K., Kaur, P., Alfonso, Z., van der Velden, V. H. J., te Marvelde, J. G., Hobo, W., Slomp, J., Bachas, C., Kelder, A., Nguyen, K. & Cloos, J., Nov 2023, In: Cytometry Part B - Clinical Cytometry. 104, 6, p. 426-439 14 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival
Tettero, J. M., Ngai, L. L., Bachas, C., Breems, D. A., Fischer, T., Gjertsen, B. T., Gradowska, P., Griskevicius, L., Janssen, J. J. W. M., Juliusson, G., Maertens, J., Manz, M. G., Pabst, T., Passweg, J., Porkka, K., Valk, P. J. M., Löwenberg, B., Ossenkoppele, G. J. & Cloos, J., 1 Oct 2023, In: Haematologica. 108, 10, p. 2794-2798 5 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications